Crossmark

Comparison of Intralesional Placentrex Versus Hyaluronidase and Dexamethasone Injection in the Symptomatic Management of Stage II Oral Submucous Fibrosis - a Prospective Study

Crossref DOI link: https://doi.org/10.1007/s12070-023-04016-5

Published Online: 2023-07-04

Published Print: 2023-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

EK, Joshna https://orcid.org/0000-0002-6289-4252
John, Bobby

Sharma, Ankit

Poorna T, Anish

Pangarikar, Anunay

Raj, Vishnu
License Information

Text and Data Mining valid from 2023-07-04

Version of Record valid from 2023-07-04
More Information

Article History

Received: 5 June 2023

Accepted: 21 June 2023

First Online: 4 July 2023

Declarations

:

: Written informed consent was obtained from the patients for their inclusion in the study.

: Ethical clearance was obtained from the Institutional Review Board for study purpose.

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below